annual EBITDA:
$49.90M+$23.80M(+91.20%)Summary
- As of today (June 22, 2025), TGTX annual EBITDA is $49.90 million, with the most recent change of +$23.80 million (+91.20%) on December 31, 2024.
- During the last 3 years, TGTX annual EBITDA has risen by +$391.87 million (+114.59%).
- TGTX annual EBITDA is now at all-time high.
Performance
TGTX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$12.22M-$20.35M(-62.47%)Summary
- As of today (June 22, 2025), TGTX quarterly EBITDA is $12.22 million, with the most recent change of -$20.35 million (-62.47%) on March 1, 2025.
- Over the past year, TGTX quarterly EBITDA has increased by +$20.53 million (+247.15%).
- TGTX quarterly EBITDA is now -89.62% below its all-time high of $117.77 million, reached on September 30, 2023.
Performance
TGTX quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$70.56M+$20.53M(+41.04%)Summary
- As of today (June 22, 2025), TGTX TTM EBITDA is $70.56 million, with the most recent change of +$20.53 million (+41.04%) on March 1, 2025.
- Over the past year, TGTX TTM EBITDA has increased by +$16.51 million (+30.53%).
- TGTX TTM EBITDA is now -35.00% below its all-time high of $108.56 million, reached on June 30, 2024.
Performance
TGTX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
TGTX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +91.2% | +247.2% | +30.5% |
| 3 y3 years | +114.6% | +118.5% | +122.1% |
| 5 y5 years | +129.8% | +124.5% | +138.6% |
TGTX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +114.6% | -89.6% | +116.2% | -35.0% | +122.1% |
| 5 y | 5-year | at high | +114.6% | -89.6% | +113.3% | -35.0% | +120.6% |
| alltime | all time | at high | +114.6% | -89.6% | +113.3% | -35.0% | +120.6% |
TGTX EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $12.22M(-62.5%) | $70.56M(+41.0%) |
| Dec 2024 | $49.90M(+91.2%) | $32.58M(+114.8%) | $50.03M(+740.6%) |
| Sep 2024 | - | $15.16M(+43.1%) | $5.95M(-94.5%) |
| Jun 2024 | - | $10.60M(-227.6%) | $108.56M(+100.8%) |
| Mar 2024 | - | -$8.31M(-27.8%) | $54.06M(+107.1%) |
| Dec 2023 | $26.10M(-112.2%) | -$11.50M(-109.8%) | $26.10M(-168.9%) |
| Sep 2023 | - | $117.77M(-368.3%) | -$37.88M(-80.0%) |
| Jun 2023 | - | -$43.90M(+21.0%) | -$189.69M(+3.6%) |
| Mar 2023 | - | -$36.27M(-52.0%) | -$183.15M(-14.1%) |
| Dec 2022 | -$213.11M(-37.7%) | -$75.48M(+121.7%) | -$213.11M(-7.2%) |
| Sep 2022 | - | -$34.04M(-8.9%) | -$229.75M(-18.0%) |
| Jun 2022 | - | -$37.36M(-43.6%) | -$280.18M(-12.3%) |
| Mar 2022 | - | -$66.22M(-28.1%) | -$319.57M(-6.5%) |
| Dec 2021 | -$341.97M(+25.4%) | -$92.13M(+9.1%) | -$341.97M(+1.6%) |
| Sep 2021 | - | -$84.47M(+10.1%) | -$336.66M(-0.3%) |
| Jun 2021 | - | -$76.75M(-13.4%) | -$337.65M(+8.4%) |
| Mar 2021 | - | -$88.62M(+2.1%) | -$311.46M(+14.2%) |
| Dec 2020 | -$272.68M(+63.0%) | -$86.82M(+1.6%) | -$272.68M(+22.0%) |
| Sep 2020 | - | -$85.46M(+69.0%) | -$223.46M(+12.7%) |
| Jun 2020 | - | -$50.57M(+1.5%) | -$198.32M(+8.5%) |
| Mar 2020 | - | -$49.83M(+32.5%) | -$182.82M(+9.3%) |
| Dec 2019 | -$167.30M(-2.9%) | -$37.60M(-37.7%) | -$167.30M(-8.7%) |
| Sep 2019 | - | -$60.32M(+72.0%) | -$183.28M(+17.1%) |
| Jun 2019 | - | -$35.07M(+2.2%) | -$156.57M(-5.3%) |
| Mar 2019 | - | -$34.31M(-36.0%) | -$165.40M(-4.2%) |
| Dec 2018 | -$172.38M(+46.8%) | -$53.58M(+59.4%) | -$172.64M(+16.0%) |
| Sep 2018 | - | -$33.61M(-23.4%) | -$148.87M(+1.4%) |
| Jun 2018 | - | -$43.90M(+5.6%) | -$146.83M(+11.8%) |
| Mar 2018 | - | -$41.56M(+39.4%) | -$131.33M(+11.8%) |
| Dec 2017 | -$117.42M(+48.8%) | -$29.81M(-5.6%) | -$117.42M(+5.2%) |
| Sep 2017 | - | -$31.56M(+11.1%) | -$111.62M(+6.3%) |
| Jun 2017 | - | -$28.40M(+2.7%) | -$104.96M(+13.4%) |
| Mar 2017 | - | -$27.65M(+15.2%) | -$92.57M(+17.3%) |
| Dec 2016 | -$78.91M(+24.9%) | -$24.01M(-3.6%) | -$78.91M(+7.4%) |
| Sep 2016 | - | -$24.91M(+55.6%) | -$73.47M(+18.6%) |
| Jun 2016 | - | -$16.01M(+14.4%) | -$61.97M(-1.3%) |
| Mar 2016 | - | -$13.99M(-24.7%) | -$62.81M(-0.6%) |
| Dec 2015 | -$63.16M(+13.4%) | -$18.57M(+38.5%) | -$63.16M(-1.3%) |
| Sep 2015 | - | -$13.40M(-20.5%) | -$64.03M(-5.6%) |
| Jun 2015 | - | -$16.85M(+17.5%) | -$67.84M(+8.1%) |
| Mar 2015 | - | -$14.34M(-26.2%) | -$62.73M(+12.6%) |
| Dec 2014 | -$55.72M(+185.4%) | -$19.43M(+12.9%) | -$55.72M(+33.6%) |
| Sep 2014 | - | -$17.22M(+46.5%) | -$41.71M(+44.8%) |
| Jun 2014 | - | -$11.75M(+60.5%) | -$28.81M(+23.1%) |
| Mar 2014 | - | -$7.32M(+35.0%) | -$23.40M(+19.9%) |
| Dec 2013 | -$19.52M(-21.7%) | -$5.42M(+25.7%) | -$19.52M(+14.5%) |
| Sep 2013 | - | -$4.32M(-32.0%) | -$17.04M(+12.1%) |
| Jun 2013 | - | -$6.34M(+84.3%) | -$15.21M(+35.7%) |
| Mar 2013 | - | -$3.44M(+17.0%) | -$11.21M(-55.1%) |
| Dec 2012 | -$24.95M(+2728.5%) | -$2.94M(+18.6%) | -$24.95M(+10.6%) |
| Sep 2012 | - | -$2.48M(+5.8%) | -$22.56M(+12.2%) |
| Jun 2012 | - | -$2.35M(-86.3%) | -$20.11M(+11.3%) |
| Mar 2012 | - | -$17.18M(+2995.4%) | -$18.06M(-5.7%) |
| Dec 2011 | -$882.00K(-56.2%) | -$554.90K(+1743.5%) | -$19.15M(-12.2%) |
| Sep 2011 | - | -$30.10K(-89.9%) | -$21.81M(+2.0%) |
| Jun 2011 | - | -$297.00K(-98.4%) | -$21.39M(-1.0%) |
| Mar 2011 | - | -$18.27M(+468.7%) | -$21.61M(+458.0%) |
| Dec 2010 | -$2.01M | -$3.21M(-921.2%) | -$3.87M(+286.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2010 | - | $391.10K(-174.7%) | -$1.00M(-44.0%) |
| Jun 2010 | - | -$523.50K(-1.0%) | -$1.79M(+2.7%) |
| Mar 2010 | - | -$528.60K(+55.4%) | -$1.74M(-1.5%) |
| Dec 2009 | -$1.77M(-59.7%) | -$340.10K(-13.8%) | -$1.77M(+28.8%) |
| Sep 2009 | - | -$394.40K(-17.1%) | -$1.37M(-41.7%) |
| Jun 2009 | - | -$475.80K(-14.4%) | -$2.35M(-29.5%) |
| Mar 2009 | - | -$555.80K(-1108.7%) | -$3.34M(-23.9%) |
| Dec 2008 | -$4.39M(-63.7%) | $55.10K(-104.0%) | -$4.39M(-30.9%) |
| Sep 2008 | - | -$1.38M(-5.7%) | -$6.35M(-17.2%) |
| Jun 2008 | - | -$1.46M(-9.1%) | -$7.67M(-31.0%) |
| Mar 2008 | - | -$1.61M(-15.9%) | -$11.12M(-8.0%) |
| Dec 2007 | -$12.10M(+21.7%) | -$1.91M(-29.1%) | -$12.10M(-9.4%) |
| Sep 2007 | - | -$2.70M(-45.1%) | -$13.35M(+5.9%) |
| Jun 2007 | - | -$4.91M(+90.4%) | -$12.60M(+25.6%) |
| Mar 2007 | - | -$2.58M(-18.5%) | -$10.04M(+1.0%) |
| Dec 2006 | -$9.94M(-48.5%) | -$3.16M(+62.3%) | -$9.94M(-53.3%) |
| Sep 2006 | - | -$1.95M(-16.7%) | -$21.29M(+0.4%) |
| Jun 2006 | - | -$2.34M(-5.6%) | -$21.20M(+4.2%) |
| Mar 2006 | - | -$2.48M(-82.9%) | -$20.35M(+5.5%) |
| Dec 2005 | -$19.30M(+220.9%) | -$14.51M(+679.7%) | -$19.29M(+195.7%) |
| Sep 2005 | - | -$1.86M(+25.1%) | -$6.52M(-5.0%) |
| Jun 2005 | - | -$1.49M(+4.4%) | -$6.87M(+8.5%) |
| Mar 2005 | - | -$1.42M(-18.6%) | -$6.33M(+5.2%) |
| Dec 2004 | -$6.01M(+31.6%) | -$1.75M(-20.6%) | -$6.01M(+4.0%) |
| Sep 2004 | - | -$2.20M(+131.5%) | -$5.78M(+3.8%) |
| Jun 2004 | - | -$951.60K(-14.3%) | -$5.57M(+5.1%) |
| Mar 2004 | - | -$1.11M(-26.9%) | -$5.30M(+16.0%) |
| Dec 2003 | -$4.57M(+359.0%) | -$1.52M(-23.7%) | -$4.57M(+58.5%) |
| Sep 2003 | - | -$1.99M(+192.3%) | -$2.88M(+94.6%) |
| Jun 2003 | - | -$680.80K(+79.1%) | -$1.48M(+41.2%) |
| Mar 2003 | - | -$380.20K(-325.9%) | -$1.05M(-18.5%) |
| Dec 2002 | -$995.50K(-67.3%) | $168.30K(-128.6%) | -$1.29M(-35.7%) |
| Sep 2002 | - | -$588.20K(+136.4%) | -$2.00M(-5.0%) |
| Jun 2002 | - | -$248.80K(-59.8%) | -$2.11M(-36.4%) |
| Mar 2002 | - | -$618.40K(+13.1%) | -$3.32M(+14.5%) |
| Dec 2001 | -$3.04M(-1.5%) | -$547.00K(-21.1%) | -$2.89M(>+9900.0%) |
| Sep 2001 | - | -$693.40K(-52.4%) | -$5400.00(-97.9%) |
| Jun 2001 | - | -$1.46M(+637.8%) | -$256.70K(-86.4%) |
| Mar 2001 | - | -$197.40K(-108.4%) | -$1.88M(-38.7%) |
| Dec 2000 | -$3.09M(+18.7%) | $2.34M(-347.9%) | -$3.07M(-48.9%) |
| Sep 2000 | - | -$944.70K(-69.3%) | -$6.01M(+8.0%) |
| Jun 2000 | - | -$3.08M(+122.1%) | -$5.57M(+74.7%) |
| Mar 2000 | - | -$1.39M(+131.2%) | -$3.19M(+13.8%) |
| Dec 1999 | -$2.60M(-13.3%) | -$600.00K(+20.0%) | -$2.80M(-20.0%) |
| Sep 1999 | - | -$500.00K(-28.6%) | -$3.50M(-16.7%) |
| Jun 1999 | - | -$700.00K(-30.0%) | -$4.20M(+55.6%) |
| Mar 1999 | - | -$1.00M(-23.1%) | -$2.70M(-10.0%) |
| Dec 1998 | -$3.00M(-42.3%) | -$1.30M(+8.3%) | -$3.00M(-9.1%) |
| Sep 1998 | - | -$1.20M(-250.0%) | -$3.30M(+6.5%) |
| Jun 1998 | - | $800.00K(-161.5%) | -$3.10M(-44.6%) |
| Mar 1998 | - | -$1.30M(-18.8%) | -$5.60M(+9.8%) |
| Dec 1997 | -$5.20M(+40.5%) | -$1.60M(+60.0%) | -$5.10M(+10.9%) |
| Sep 1997 | - | -$1.00M(-41.2%) | -$4.60M(-2.1%) |
| Jun 1997 | - | -$1.70M(+112.5%) | -$4.70M(+30.6%) |
| Mar 1997 | - | -$800.00K(-27.3%) | -$3.60M(+33.3%) |
| Dec 1996 | -$3.70M | -$1.10M(0.0%) | -$2.70M(+68.8%) |
| Sep 1996 | - | -$1.10M(+83.3%) | -$1.60M(+220.0%) |
| Jun 1996 | - | -$600.00K(-700.0%) | -$500.00K(-600.0%) |
| Mar 1996 | - | $100.00K | $100.00K |
FAQ
- What is TG Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for TG Therapeutics?
- What is TG Therapeutics annual EBITDA year-on-year change?
- What is TG Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for TG Therapeutics?
- What is TG Therapeutics quarterly EBITDA year-on-year change?
- What is TG Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for TG Therapeutics?
- What is TG Therapeutics TTM EBITDA year-on-year change?
What is TG Therapeutics annual EBITDA?
The current annual EBITDA of TGTX is $49.90M
What is the all time high annual EBITDA for TG Therapeutics?
TG Therapeutics all-time high annual EBITDA is $49.90M
What is TG Therapeutics annual EBITDA year-on-year change?
Over the past year, TGTX annual EBITDA has changed by +$23.80M (+91.20%)
What is TG Therapeutics quarterly EBITDA?
The current quarterly EBITDA of TGTX is $12.22M
What is the all time high quarterly EBITDA for TG Therapeutics?
TG Therapeutics all-time high quarterly EBITDA is $117.77M
What is TG Therapeutics quarterly EBITDA year-on-year change?
Over the past year, TGTX quarterly EBITDA has changed by +$20.53M (+247.15%)
What is TG Therapeutics TTM EBITDA?
The current TTM EBITDA of TGTX is $70.56M
What is the all time high TTM EBITDA for TG Therapeutics?
TG Therapeutics all-time high TTM EBITDA is $108.56M
What is TG Therapeutics TTM EBITDA year-on-year change?
Over the past year, TGTX TTM EBITDA has changed by +$16.51M (+30.53%)